Ulysses® VR Upper Limb Therapy System is clinically designed and research based
Ulysses® is now available in Australia (included in the ARTG, No. 402309) and the United Kingdom (UKCA marked) for acquiring and enhancing skills for improving overall functional upper-limb mobility
Evaluated in a clinical setting
An independent, TGA registered¹ clinical trial conducted by qualified occupational therapists and physiotherapists at the University of Newcastle Research Centre in Tamworth, New South Wales, Australia evaluated the efficacy, engagement, comfort and adverse events when using a VR headset with Ulysses software.
Five participants completed a total of 15 sessions each using the Ulysses system over the course of the 5-week study.
The study’s primary objective was functional performance of the upper limb. Pre and post assessments were performed to measure each participant’s functional improvement using the Motor Assessment Scale and Fugl Meyer Scale.
Secondary outcomes related to the participant’s level of engagement, comfortability and motivation to continue using the system were collected in an exit survey at the conclusion of the trial.
Participants ranged in age from 50-78 and had suffered a haemorrhagic or ischaemic stroke.
Time since the stroke ranged from 18 months to 17 years.
Cognitive capacity ranged from significant to mild impairment (as measured on the Montreal Cognitive Assessment Scale from 11 to 25).
Time since the stroke ranged from 18 months to 17 years.
Cognitive capacity ranged from significant to mild impairment (as measured on the Montreal Cognitive Assessment Scale from 11 to 25).
3 out of 5 participants demonstrated improved functional mobility as measured by the Motor Assessment Scale.
4 out of 5 participants showed improved functional mobility as measured by the Fugl Meyer Scale.
4 out of 5 participants showed improved functional mobility as measured by the Fugl Meyer Scale.
Participants ranged in age from 50-78 and had suffered a haemorrhagic or ischaemic stroke.
Time since the stroke ranged from 18 months to 17 years.
Cognitive capacity ranged from significant to mild impairment (as measured on the Montreal Cognitive Assessment Scale from 11 to 25).
Time since the stroke ranged from 18 months to 17 years.
Cognitive capacity ranged from significant to mild impairment (as measured on the Montreal Cognitive Assessment Scale from 11 to 25).
3 out of 5 participants demonstrated improved functional mobility as measured by the Motor Assessment Scale.
4 out of 5 participants showed improved functional mobility as measured by the Fugl Meyer Scale.
4 out of 5 participants showed improved functional mobility as measured by the Fugl Meyer Scale.
Rated highly for comfort, engagement, and motivation.
On the scale of likeability, participants rated the Ulysses system an average of 80 out of 100.
The system was also rated on comfortability, where an average score of 79 out of 100 was recorded, with only a small number of cases reporting mild discomfort from wearing the headset and being in a VR environment.
All participants responded positively when asked if they would like to continue using the Ulysses system, providing a 76 out of 100 average rating.
